DOKTERS MAELEGHEER-SURMONT
0873.409.774 · rovalta.com · 26/09/2026
NORMAL SITUATION
DOKTERS MAELEGHEER-SURMONT
Company — Normal situation.
Financial year 2024 · Closed on 31/12/2024
Net result-1,4 k €+96,5 %over 1 year
Gross margin-9,1 k €+47,0 %over 1 year
Equity80 k €-54,4 %over 1 year
Overview
Identity
Source · BCE/KBODOKTERS MAELEGHEER-SURMONT is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0873.409.774
- Legal form
- Private company with limited liability
- Contributed capital
- 6 200,00 €
- Latest accounts
- 31/12/2024
Signals
Solid equityGood liquidity
Financials
Source · NBB, 18 filingsTrend over 16 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -9,1 k € | +47.0% | -17,2 k € | -357% | 6,7 k € | -63.2% | 18,2 k € | -43.3% | 32 k € |
| EBITDA | -9,2 k € | +47.1% | -17,4 k € | -371% | 6,4 k € | -63.9% | 17,8 k € | -43.3% | 31,4 k € |
| Operating result | -9,2 k € | +47.1% | -17,4 k € | -1840% | 1 k € | -90.0% | 10 k € | -57.6% | 23,6 k € |
| Net result | -1,4 k € | +96.5% | -39,5 k € | -1409% | -2,6 k € | -146% | 5,7 k € | -70.4% | 19,2 k € |
| Balance sheet | |||||||||
| Equity | 80 k € | -54.4% | 175,6 k € | -19.0% | 216,7 k € | -1.2% | 219,3 k € | +1.9% | 215,3 k € |
| Total assets | 81,6 k € | -54.0% | 177,4 k € | -18.7% | 218,2 k € | -2.7% | 224,4 k € | +0.5% | 223,3 k € |
| Cash | – | 89 k € | -10.7% | 99,6 k € | +5.0% | 94,9 k € | +5.0% | 90,3 k € | |
| Debts | 1,6 k € | -9.2% | 1,8 k € | +15.5% | 1,5 k € | -69.6% | 5 k € | -37.2% | 8 k € |
Board of directors
Source · NBB, accounts to 31/12/20242 active · 5 ended
Active mandates
ANN SURMONT
ActiveMARIO MAELEGHEER
ActiveEnded mandates
Ann Surmont
EndedMario Maelegheer
EndedMARIO MAELEGHEER
EndedMARIO MAELEGHEER
EndedFinancials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/08/2025 | 20/06/2024 | 29/09/2023 | 29/09/2023 | 31/12/2021 | 07/12/2020 |
| General meeting | 27/05/2025 | 01/06/2024 | 21/09/2023 | 21/09/2022 | 28/10/2021 | 26/11/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 18 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2024 | 27/05/2025 | 31/08/2025 | Dutch | |
| Micro model | 31/12/2023 | 01/06/2024 | 20/06/2024 | Dutch | |
| Micro model | 31/12/2022 | 21/09/2023 | 29/09/2023 | Dutch | |
| Micro model | 31/12/2021 | 21/09/2022 | 29/09/2023 | Dutch | |
| Micro model | 31/12/2020 | 28/10/2021 | 31/12/2021 | Dutch | |
| Micro model | 31/12/2019 | 26/11/2020 | 07/12/2020 | Dutch | |
| Micro model | 31/12/2018 | 30/09/2019 | 20/11/2019 | Dutch | |
| Micro model | 31/12/2017 | 30/09/2018 | 08/11/2019 | Dutch | |
| Micro model | 31/12/2016 | 26/09/2017 | 30/09/2017 | Dutch | |
| Abridged model | 31/12/2015 | 21/09/2016 | 02/10/2016 | Dutch | |
| Abridged model | 31/12/2013 | 21/09/2014 | 01/10/2014 | Dutch | |
| Abridged model | 31/12/2012 | 30/09/2013 | 07/10/2013 | Dutch | |
| Abridged model | 31/12/2011 | 30/09/2012 | 19/11/2012 | Dutch | |
| Abridged model | 31/12/2010 | 30/09/2011 | 03/11/2011 | Dutch | |
| Abridged model | 31/12/2009 | 30/09/2010 | 03/11/2011 | Dutch | |
| Abridged model | 31/12/2008 | 30/09/2009 | 18/05/2010 | Dutch | |
| Abridged model | 31/12/2007 | 15/09/2008 | 29/12/2008 | Dutch | |
| Abridged model | 31/12/2006 | 24/09/2007 | 28/09/2007 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20242 active · 5 ended
Active mandates
ANN SURMONT
ActiveMARIO MAELEGHEER
ActiveEnded mandates
Ann Surmont
EndedMario Maelegheer
EndedMARIO MAELEGHEER
EndedMARIO MAELEGHEER
EndedOwnership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024-1,4 k €↑
- 2024Name changeDokters Maelegheer-Surmont
- 2023Annual accounts 2023-39,5 k €↓
- 2022Annual accounts 2022-2,6 k €↓
- 2021Annual accounts 20215,7 k €↓
- 2021Name changeMAELEGHEER-SURMONT
- 2020Annual accounts 202019,2 k €↑
- 2019Annual accounts 201912,2 k €↑
- 2018Annual accounts 201811,2 k €↓
- 2017Annual accounts 201723,7 k €↓
- 2016Annual accounts 201637,7 k €↓
- 2015Annual accounts 201546,6 k €↓
- 2013Annual accounts 201354,6 k €↑
- 2012Annual accounts 201228,1 k €↑
- 2011Annual accounts 201126,1 k €↑
- 2010Annual accounts 201021,3 k €↓
- 2009Annual accounts 200940,8 k €↑
- 2008Annual accounts 20089,5 k €